Clinical Trial Update: Pilot Study of COR-1 in Heart Failure [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 pilot trial of COR-1 in patients with dilated cardiomyopathy (heart failure), with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• COR-1

Snippet

Sponsor: Corimmun GmbH | Conditions: Cardiomyopathy, Dilated | Phase 2 | Status: COMPLETED | Results posted: 2014-08-26